Skip to main content

Detecting consolidation deficits before standard tests can

Individuals reporting memory concerns that do not yet appear on standard neuropsychological tests represent the earliest identifiable stage of cognitive decline. Research on accelerated long-term forgetting demonstrates measurable consolidation deficits in this population years before objective impairment on conventional instruments.

12-24 hrs
ALF Detection Window
Published ALF research
Near floor
Standard Test Sensitivity
SMC scores normal on MMSE/MoCA
~7 years
Presymptomatic Detection
Weston et al., Lancet Neurology
Remote
Administration
AI-administered, no site visit

The SMC Detection Problem

By definition, individuals with subjective memory complaint score within normal ranges on standard cognitive tests. ADAS-Cog, MMSE, and MoCA all use short delay intervals (under 30 minutes) that test encoding and short-term retention. These instruments cannot detect the consolidation failures that characterize the earliest stages of Alzheimer pathology. Prevention trials targeting this population need endpoints sensitive enough to measure change in a cognitively "normal" group.

Why Consolidation Matters for SMC

Research on accelerated long-term forgetting (ALF) shows that individuals with subjective memory concerns can encode and retain information normally over short intervals but show significant forgetting over 24 hours or longer. This pattern reflects disruption of hippocampal-neocortical memory transfer during sleep. FaceWise captures this overnight window, providing a measurement domain that no standard cognitive battery addresses.

Published Evidence

Research supporting consolidation-based endpoints for subjective memory complaint assessment.

Accelerated Long-Term Forgetting in Preclinical AD

A Lancet Neurology study detected accelerated long-term forgetting in presymptomatic autosomal dominant Alzheimer disease carriers approximately 7 years before estimated symptom onset. Standard 30-minute recall failed to detect any deficit in the same participants.

Weston PSJ, et al. Lancet Neurology, 2018. DOI: 10.1016/S1474-4422(18)30028-8

FNAME Sensitivity in Normal-Range Populations

The Face-Name Associative Memory Exam was ranked first among 61 cognitive assessments for predicting Alzheimer progression in the ARMADA study. Its sensitivity in high-performing populations makes it particularly suited for SMC cohorts.

Rentz DM, et al. Alzheimers Dement, 2022 (ARMADA study)

Sleep-Dependent Consolidation Disruption

Amyloid-beta accumulation disrupts slow-wave sleep and impairs hippocampal replay, the mechanism through which memories are consolidated to long-term cortical storage. This disruption is detectable before clinical symptoms emerge.

Mander BA, et al. Nature Neuroscience, 2015. DOI: 10.1038/nn.4035

Trial Applications

Clinical trial contexts where FaceWise consolidation endpoints add value for subjective memory complaint programs.

Anti-amyloid prevention trials in biomarker-positive, cognitively normal individuals
Lifestyle intervention studies measuring cognitive maintenance
Digital therapeutic trials targeting sleep quality and memory
Longitudinal observational studies tracking preclinical decline

Ready to discuss subjective memory complaint endpoints?

Schedule a consultation to explore how FaceWise consolidation endpoints can strengthen your subjective memory complaint clinical program.